IFNAR1 and infection: The immunization with rMVA/rMVA was more efficient in protection against a virulent challenge with AHSV-4 and both strategies, DNA/rMVA and rMVA/rMVA, protected against the infection with AHSV-9, serotype with a lower virulent behavior in the infections of IFNAR(−/−) mice.